![Jennifer Kaufman-Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Kaufman-Shaw
Corporate Officer/Principal chez
Zymeworks BC, Inc.
Profil
Jennifer Kaufman-Shaw was the founder of ImStar Therapeutics, Inc. (founded in 2012) where she held the title of VP-Intellectual Property & Legal Affairs from 2012 to 2014.
She is currently working as Vice President-Intellectual Property at Zymeworks BC, Inc. since 2014.
Additionally, she is a Member of the Alberta Bar Association and the British Columbia Bar Association.
In her former positions, she worked as a Director at MRM Proteomics, Inc., Vice President-Patent Counsel at QLT, Inc. from 1997 to 2007, and Vice President at Sirius Genomics, Inc. from 2007 to 2012.
Dr. Kaufman-Shaw obtained her graduate and doctorate degrees from the University of Alberta.
Postes actifs de Jennifer Kaufman-Shaw
| Sociétés | Poste | Début |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Alberta Bar Association | Corporate Officer/Principal | - |
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a law firm association to provide legal services | Corporate Officer/Principal | - |
Anciens postes connus de Jennifer Kaufman-Shaw
| Sociétés | Poste | Fin |
|---|---|---|
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for ALS and neurodegenerative disease | Fondateur | 01/07/2014 |
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Develops DNA-based diagnostic and pharmacogenetic products | Corporate Officer/Principal | 01/05/2012 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Corporate Officer/Principal | 01/07/2007 |
MRM Proteomics, Inc.
 MRM Proteomics, Inc. BiotechnologyHealth Technology Provides proteomics services and develops and sells bioassay kits through online | Directeur/Membre du Conseil | - |
Formation de Jennifer Kaufman-Shaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alberta Bar Association | |
British Columbia Bar Association
British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a law firm association to provide legal services | Commercial Services |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Develops DNA-based diagnostic and pharmacogenetic products | Health Technology |
ImStar Therapeutics, Inc.
ImStar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for ALS and neurodegenerative disease | Health Technology |
MRM Proteomics, Inc.
MRM Proteomics, Inc. BiotechnologyHealth Technology Provides proteomics services and develops and sells bioassay kits through online | Health Technology |
